SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-006199
Filing Date
2017-08-08
Accepted
2017-08-08 07:18:34
Documents
73
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q qure-20170630x10q.htm 10-Q 1974897
2 EX-10.1 qure-20170630ex101e8b4c0.htm EX-10.1 114818
3 EX-10.2 qure-20170630ex102ed5abd.htm EX-10.2 134589
4 EX-10.3 qure-20170630ex103eb709c.htm EX-10.3 116015
5 EX-10.4 qure-20170630ex10452e514.htm EX-10.4 119228
6 EX-31.1 qure-20170630ex3114bc670.htm EX-31.1 18378
7 EX-31.2 qure-20170630ex312c79373.htm EX-31.2 18271
8 EX-32.1 qure-20170630ex3212726cf.htm EX-32.1 11147
  Complete submission text file 0001558370-17-006199.txt   8001740

Data Files

Seq Description Document Type Size
9 EX-101.INS qure-20170630.xml EX-101.INS 1627333
10 EX-101.SCH qure-20170630.xsd EX-101.SCH 57330
11 EX-101.CAL qure-20170630_cal.xml EX-101.CAL 50047
12 EX-101.DEF qure-20170630_def.xml EX-101.DEF 249471
13 EX-101.LAB qure-20170630_lab.xml EX-101.LAB 496545
14 EX-101.PRE qure-20170630_pre.xml EX-101.PRE 409707
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-36294 | Film No.: 171013227
SIC: 2834 Pharmaceutical Preparations